ArticleJournal for immunotherapy of cancer2025

Potency-optimized CD28-activating bispecific antibody for the targeted treatment of Nectin-4 positive cancers.

Manpreet Kaur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.